The aim of this study was to assess the effects of Sangrovit®, a standardized preparation of Macleaya cordata extract (MCE), on the health status and performance in weaned piglets. A total of 128 weaned piglets were randomly divided into four groups (n = 32, 16/sex/group) and fed either a control feed (T1) or the control feed supplemented with 100 mg/kg (T2), 500 mg/kg (T3), or 1000 mg/kg (T4) Sangrovit® (resulting in 0, 3.5, 17.5, 35 mg MCE/kg feed, respectively) for ninety days. The parameters for growth and health status were evaluated during the trial and blood was collected on Day 0 and Day 91 for hematology and biochemistry analysis. After the animals were sacrificed,
Introduction
Macleaya cordata (M. cordata) is a deciduous perennial plant found across North America, Eastern Asia, and European countries. It is hollow-stemmed, leafy and fast growing and can grow to 2.0 meters high [1] . Previous studies have shown that the aerial parts of M. cordata contain a variety of quaternary benzophenanthridine alkaloids (QBAs) that display multiple biological activities. Isolation of QBA, though in impure form, was first reported in the first half of the 19th century. Other forms of QBA have been discovered since then and in the mid-1980s approximately 80 naturally occurring compounds of this type were reported [2] . Long before pure alkaloids were isolated, plants of the Papaveraceae family containing QBAs such as sanguinarine and chelerythrine, including the plant Sanguinaria canadensis (blood root) that contains 4% -7% QBA in rhizome and 1.8% in roots, Chelidonium majus (celandine) that contains 4.5% QBA in roots, and M. cordata that contains 3% QBA in aerial parts, were utilized in traditional medicine in North America, Europe and China for analgesic, antiedemic, carminative, depurative, and diuretic properties [3] .
Among the alkaloid varieties, sanguinarine and chelerythrine are colorless and crystalline substances that have been well investigated for their unique properties [1] [4] . Sanguinarine and chelerythrine are bitter in taste and products containing these substances have been used as natural appetizing agents to feed farm animals, such as swine [3] , bovines [5] , poultry [6] and fish [7] . Swine (Sus scrofa domesticus L.) is one of the most important commercial livestock species that provides more than one third of the meat production in the world [8] . Previous studies have found that the bitter taste is a part of the swine taste receptor system [9] and QBAs from M. cordata have been identified as flavoring compounds [10] which could potentially improve palatability of animal feed like some other phytogenic compounds [11] . In this study, M. cordata extract (MCE), a bitter tasting substance, is proposed to provide a consistent taste to the feed, and to mask subtle changes that may affect feed intake of piglets.
MCE has been included in the European Feed Additive Register and approved for use as a flavoring compound for farm animals. Sangrovit® is a standardized preparation of MCE, manufactured by an ethanol-based extraction of the aerial portions of the M. cordata plant, which contains 3.5% MCE (providing 1.5% sanguinarine). The recommended use rate for Sangrovit® to be added to premixes or to compound feed is 15 -100 mg/kg in feed. Dietary supplementation with
Sangrovit® has been demonstrated to elevate daily body weight gain and feed conversion ratio in chickens [12] [13] and optimize the nitrogen utilization and feed digestion in bovine [5] [14] . In swine, Sangrovit® has been evaluated for its effects on stress response and pathogen shedding in finishing pigs [15] and ef-fects on the growth parameters in weaning piglets [3] . However, few studies have been conducted to assess the safety of MCE consumption in weaned piglets. The objective of this study was to determine the tolerability and health status of consumption of Sangrovit®, a standardized preparation of MCE that contains sanguinarine and chelerythrine as major active components, for 90 days by weaned piglets at the levels of 100, 500, 1000 mg Sangrovit®/kg feed.
Materials and Methods

Test Substance
A manufactured preparation of MCE, under the trade name of Sangrovit®, was provided by Phytobiotics Futterzusatzstoffe GmbH (Eltville, Germany) and used as the test substance for all the experiments in this study. The Sangrovit® preparation was a reddish-orange-green colored granula that was standardized to contain at least 1.5% sanguinarine resulting in about 3.5% MCE. The level of sanguinarine and chelerythrine in Sangrovit® in the feed were measured by validated methods as previously described [12] . No microbiological contamination such as Salmonella was detected after analysis, and heavy metal content was within limits set in the legislation of the European Union (Arsenic: <2 mg/kg; Mercury: <0.1 mg/kg; Cadmium: <1 mg/kg; Lead: <10 mg/kg).
Experimental Animals and Diets
This trial was carried out on 128 hybrid piglets (64 females and 64 castrated males; Bompieri × Goland genetic line that is a Large White × Duroc cross; sire line was the hybrid boar of the Bompieri line), weaned at approximately 28 days of age. The breeding farm code was 125 BS 001/6 and the farm was located in Pontevico (BS), Italy. The study was conducted in two compartments, i.e., weaning rooms and growing rooms, depending on the growth phase and weight of the animals at the CERZOO S.r.l. facility (Piacenza, Italy). The conditions were regarded as representative for a modern commercial operation in Europe. The total treatment duration was 90 days, plus an acclimatization period of 7 days before the study started. After the acclimatization period, the animals were weighed, selected for healthy individuals, and assigned to the control and treatment groups to achieve maximum possible homogeneity within each group and minimize differences between the groups. An average of live weight (LW) was 7.83 (±0.89) kg when piglets entered the study on Day 0 (D0). Four piglets of the same gender were housed in one cage, with eight cages per treatment group (i.e., 16 castrated males and 16 females/group). For the first 42 days (D0 -D41) of the study, the animals were housed in the weaning rooms in flat-deck cages. For the remaining 48 days (D42 -D90) of the study, the animals were housed in the growing room on a slatted floor. The trial facility was equipped with a dynamic ventilation system that enabled the facility to control the ventilation rate according to the temperature and age of the pigs. The temperature (27.1˚C ± 1.0˚C) and relative humidity (62.4% ± 8.6%) in the weaning room and growing room were recorded every 30 min. The temperature was automatically adjusted as necessary. Natural daylight was utilized as a light source during the whole trial period.
The weaned piglets were fed with typical corn-soybean meal-based basal diets in dry powder form, the compositions of which were changed to meet or exceed the nutrient requirements recommended for piglets in different growth stages (NRC 2012 
Study Design
Piglets were divided into four groups with equal sex distribution in each group.
The minimum sample size to pick up differences in 1 kg live weight between each treatment was calculated and a sufficient sample size of n = 32 was utilized for each group (16 castrated males and 16 females/group). The animals were fed with either a control diet (T1) or one of the three treatment diets supplemented with 100 (T2), 500 (T3) and 1000 (T4) mg Sangrovit®/kg feed for ninety days.
Daily inspections were carried out by qualified personnel while periodic inspections were made during the study by veterinarians and responsible staff of animal welfare. Individual LW of the piglets was recorded on Day 0, 21, 42 and 90.
Average daily feed intake (ADFI) by cage was determined by the difference be- females for each treatment) was slaughtered, and the carcass was subjected to detailed gross necropsy. During necropsy, organs and tissue samples from all There are no statistically difference in basal ingredient composition between control and treatment diets in 3 growing periods. The mean values of composition for the basal ingredient (expect sanguinarine and chelerythrine) in T1 diets were used and represented the basal composition for all the treatment groups. 4 The data was obtained from first batch manufactured. The data from second batch were similar (not shown).
groups (T1, T2, T3, and T4) were preserved for histopathology evaluation. This 
Diarrhea Scoring
General health status of the animals was checked twice daily. Subjective diarrhea scores were recorded daily. Diarrhea scores on cage basis were determined based on the performance of individual pigs and signs of stool consistency in the cage, ranging from 1 -3 (1 = well-formed feces; 2 = sloppy feces; 3 = diarrhea) [16] [17].
Blood Biochemistry and Hematological Analysis
Blood collections were conducted at the beginning and the end of the trial. On 
Veterinary Necropsy and Histopathology Examination
At the end of the study (Day 91), 32 experimental animals (8 animals/treatment; the same animals used for the blood collection) were necropsied by a veterinary surgeon at CERZOO. A gross examination was carried out on the organs and tissues, which included a gross check on: pituitary gland, brain, bone and marrow, kidneys, thyroid gland, spinal cord, marrow smear, caecum, eyes, spleen, urinary bladder, adrenal gland, lung, stomach, thymus, pancreas, muscle, duodenum, heart, ovaries (for females), mammary gland (for female), jejunum, 
Statistical Analysis
Results and Discussion
During the study period, the general health status of piglets was normal with no mortality and morbidity observed in different treatment groups. The fecal scoring results didn't show any statistically significant differences between control and treatment groups (all P > 0.05, Table 2 ). The LW and ADFI for the weaned piglets during three growing stages (D0 -D21, D21 -D42 and D42 -D90) and the whole 90-day trial period (D0 -D90) are shown in Table 3 . There were no significant differences in LW between the control (T1) and treatment groups (T2, T3, T4 group, fed with 100, 500, 1000 mg Sangrovit®/kg feed) during the three growing stages (treatment effect P > 0.05 for both sex). Additionally, no statistically significant differences were observed among different feeding groups (treatment effect P > 0.05 for both sex) in ADG,ADFI, and F:G over different growth stages and the whole 90-day trial period. It is noted that there was a statistically significant treatment × sex interaction in ADFI for the whole study period (P = 0.0305), but the interaction was not observed in other performance parameters (all P > 0.05). A statistical analysis by each sex was conducted and no statistically significant differences were found in ADFI in separated sex. The results are in agreement with previous findings in which 21-day-old hybrid piglets fed a basal feed supplemented with 2 mg MCE (containing 1.28 mg sanguinarine and 0.44 mg chelerythrine)/kg feed and 100 mg MCE (containing 64.03 mg sanguinarine and 21.99 mg chelerythrine)/kg feed for 90 days displayed growth characteristics (e.g., feed conversion efficiency) very similar to the corresponding control piglets [18] . However, Kantas et al. [3] found that supplementation of 50 mg/kg Sangrovit® (containing 0.75 mg/kg sanguinarine) in the feed significantly increased feed consumption and feed conversion ratio in six-week-old piglets, which is not observed in this study. The discrepancy between different studies may be attributed to different sample size, difficulty in showing significant growth changes in short period or growth variation in different swine breeds, as Jeroch et al. [19] reported that Sangrovit® exerted a significant effect on performance results (body weight gain, feed conversion ratio) in two out of four experiment conducted on different swine breeds, but there were no effects During the 90 days of this experiment, all animals remained apparently healthy and manifested no signs of toxicity. The results of the hematology on D91 were summarized in Table 4 . The majority of the parameters displayed no significant changes between the control and treatment groups. Some hematological parameters were statistically different between treatments, including MCV, MCH, platelets (treatment effect P < 0.05 for all animals). As there were statistically significant (treatment × sex) interactions for MCV and platelets (P < 0.05), a statistical analysis for each sex was conducted and the comparison was presented by sex as below. For the female piglets, the mean corpuscular volume (MCV) was statistically significantly higher in the T2 and T3 groups (100 and 500 mg/kg Sangrovit® in feed) than those in the T1 (control) group. The platelet concentration in the T3 and T4 group (500 and 1000 mg/kg Sangrovit® in feed)
were significantly lower relative to those in the T1 (control) group. For the castrated male piglets, the active partial thromboplastin time (APTT) in the T2 group was significantly lower than those in the T1 group. For the MCV changes in female piglets and APTT discrepancy in castrated male piglets, these responses were only shown in some (T2 or T3) groups but not in the other treatments (T3 and/or T4), which were not dose-dependent. Therefore, the differences in MCV and APTT were not test article related and were attributed to biological variation as the results are sporadic and not dose dependent. Platelets are a component of blood whose function is to interact with other coagulation factors and stop bleeding by clumping and clotting blood vessel injuries. Low platelet concentration was used as an indicator for thrombocytopenia and can be attributed to a decrease in platelet production or an increase in platelet destruction [20] . In this study, the low platelet count occurred in the T3 and T4 group of female piglets was not toxicological relevant as the other biomarkers for thrombocytopenia and platelet function were unchanged between groups (e.g.,
APTT and prothrombin time (PT) that are important measures for blood clotting did not altered) and no signs of bleeding and tissue damage were observed in the treatment groups. In addition, the variations in platelet count were similar to the fluctuation in control or pre-study values, and were of a magnitude of change commonly observed in weaned piglets under similar study conditions [21] .
The results of blood biochemistry analysis in the serum on D91 were summarized in Table 5 . There were no statistically significant treatment effect for majority of the parameters. However, some blood biochemistry parameters were statistically significant different between treatments, including bile acids, haptoglobin, cholesterol, creatinine kinase (CK), gamma glutamyltransferase (GGT), potassium, and total protein (treatment effect P < 0.05 for all animals).
Due to treatment × sex interactions (P < 0.05), blood biochemistry parameters were also compared for each sex and the data were presented by sex as below.
For female piglets, the bile acid concentration was significantly higher in the T2 and T3 groups, but was significantly lower for the castrated male piglets in the T3 group compared to those in the T1 group. These changes were only shown in the T2 or T3 groups but not in the other treatment (T4) group, which were not considered dose-dependent reactions. The haptoglobin level (a measure of the hemolysis) was minimally but statistically increased in all treatment groups (T2, T3 and T4) of castrated male piglets and in the T3 and T4 groups of female piglets compared to those in the T1 group. Haptoglobins are a family of hemoglobin binding proteins. A decrease in haptoglobin level was often linked to hemolytic anemia, while an increase in haptoglobin level can be attributed to inflammatory diseases or physiological changes such as acute stress [22] [23] . In this study, the increase in haptoglobin level in the treatment group did not correlate with alterations in inflammatory markers (e.g., white blood cell counts did not increase) [24] and no signs of inflammatory responses or tissue damage were observed in the animals; therefore, the variation in haptoglobin measurements is not toxicologically relevant. The total serum protein levels for castrated male piglets in the T3 and T4 group were found to be significantly lower than those in the T1 group; for female piglets, total protein level was increased in T2 group but decreased in T3 group. These variations in total protein level were consistent with the findings in other studies and considered as within normal range in weanling piglets [25] . In addition, other parameters of serum proteins such as serum albumin, and globulin levels did not change and no adverse effects or clinical signs were observed. Therefore, the changes in total protein level were not considered as a toxicologically relevant effect. Notably, lower creatine kinase (CK) activity was found in the T4 group of female piglets versus the control.
Previous studies have shown that CK activity in pigs may be affected by many factors such as stress and stocking density [26] . In general, an increase in CK activity indicates muscle damage, while a decrease has been known to occur from muscle wasting [27] . However, the T4 group did not have a significant decrease in body weights, and CK levels did not correlate with serum creatinine levels.
Therefore, the decrease in CK level in the T4 group was not toxicologically relevant. The remaining differences in blood biochemistry parameters, some of which attained statistical significance (e.g., GGT level for the female piglets in the T2 group was increased), were sporadic and not dose dependent and not test After the piglets were slaughtered, the gross morphology of the piglets' organ and the organ weights were evaluated. As shown in Table 6 , the gross examination of skin, brain, eyes, gastrointestinal tract (stomach, duodenum, jejunum, ileum, colon and caecum), major organs (pancreas, spleen, liver/gall bladder, kidneys, heart and lungs etc.), and tissue (muscle) did not reveal any pathological 1 -, not available. The statistic comparisons were conducted between control and treatment groups for the animals in the same gender (female vs. female, castrated male vs. castrated male). F = female piglets, CM = castrated male piglets, n = 4/sex in each group. Treatment effects was calculated for animals in both sex (n = 32). Score: 0 = no alteration found; 1 = slight alterations; 2 = alteration of medium intensity. No statistical differences were found between different groups (all P > 0.05).
alterations in the control and MCE-fed animals with all the scores less than 1 (score 0 means no change; score 1 means slight alteration) and all p-values greater than 0.05 between the groups. The organ weights and their percentage to LW of male and female sacrificed piglet were measured (Table 7) and no statistically significant differences were found between the treatment and control groups (all P > 0.05). Furthermore, a comprehensive histopathological examination was performed on the organs and tissues from animals in the T4 (1000 mg/kg Sangrovit® in feed) group and the T1 (control) group. Under the conditions of this study, histopathological examination didn't show the presence of any toxicity indicators in the tissues and organs examined.
MCE has been used as feed additive in animal feed for many years in Europe.
Previous studies in swine and other animal species have shown that MCE con- 
Conclusion
Based on the results in this study, the NOAEL (the no-observed-adverse-effect level) may be established at a concentration of 1000 mg/kg Sangrovit® in feed for swine, a concentration that is 10 fold of the recommended maximal concentration in feed.
